Translate Bio Inc.

(TBIO) Trade

Symbol has changed to a new ticker symbol

(TBIOD)

By |

Profile

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Contact Information

Website: www.translate.bio
Email: tdahlman@translate.bio
Main Phone: +1 617 945-7361
Address: 29 Hartwell Avenue
State: MA
City / Town: Lexington
Country: USA
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Ronald C. Renaud
Employees: 81
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News



Gathering Data... Please wait

Profile

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Contact Information

Website: www.translate.bio
Email: tdahlman@translate.bio
Main Phone: +1 617 945-7361
Address: 29 Hartwell Avenue
State: MA
City / Town: Lexington
Country: USA
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Ronald C. Renaud
Employees: 81
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 8.35 $ 0.34 (4.24%)
Last Price 8.35 Change $ 0.34 Change % 4.24 Tick N/A
Bid 7.80 Bid Size 1,100.00 Ask 8.60 Ask Size 300.00
Open 8.04 High 8.44 Low 8.00 Prev Close 8.01
Last Trade Volume 101,967 52 Wk Hi 14.34 52 Wk Low 4.81
Market Cap 425.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 51,010,368.00 EPS (TTM) -0.79 PE Ratio N/A Exchange NGS